Welcome to medications.com

Mylan Swings to a Loss on Acquisition Costs - Wall Street Journal

Mylan has a number of promising drugs in the pipeline, including a generic version of GlaxoSmithKline PLC's Lamictal tablets, an epilepsy drug with US sales ...

http://online.wsj.com/article/SB1... | Posted: Wed Feb 27 17:37:29 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com